Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation
- PMID: 53330
- DOI: 10.1016/s0140-6736(75)90235-4
Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation
Abstract
2-bromo-alpha-ergocryptine (bromocriptine) in a dosage of 2-5 mg twice daily caused a rapid fall in plasma prolactin. It was more effective than either a single dose of 4 mg quinoestrol or a placebo in suppressing puerperal lactation, as judged by milk flow and the relief of breast pain and congestion. Patients who received quinoestrol were more comfortable than those who received placebo.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
